Success Stories: A Professor, Taiwan-based, Secures I-140 NIW Approval with Our Customized Built Case
Client’s Testimonial:
“It's a really good experience to work with you. Good service and highly recommended!”
On April 9th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Professor in the Field of Pharmacology (Approval Notice).
General Field: Pharmacology
Position at the Time of Case Filing: Professor
Country of Origin: Taiwan
Approval Notice Date: April 9th, 2021
Processing Time: 11 months
Case Summary:
North America Immigration Law Group was approached to build a case under EB-2 NIW (National Interest Waiver) visa category for a professor holding a Ph.D. in pharmacology and researching the same field. When our client contacted us, as a part of our job, we evaluated his professional and academic background and confirmed that he demonstrated the impact of his work on the field, which placed him well to continue advancing the proposed project by achieving the national interest waiver approval. Thus, we made sure of all the required paperwork to put in our custom-built petition packet. Here are the following:
- We focused on his research of using pharmacotherapeutic compounds to treat cardiovascular diseases and diabetic complications. His work in this area seemed to be of great importance because it assists in developing solutions and treatments for the said diseases that affect millions of individuals.
- Additionally, we noted the 1288 citations garnered from the 57 peer-reviewed journal articles (8 of them first-authored) he published in some of the top-ranked journals, exhibiting his peers’ recognition of the significance of his investigations. Upon reviewing the publication of his work in peer-reviewed articles and citation records, we were certain that it opened the threshold for his proposed work continuation.
- Also, our client is an active member of the scientific community and completed 3 peer reviews to date, whereas only top-level experts in their field are invited to perform this important review work, our client’s participation in this peer review activity confirms his prominence in the field.
- Furthermore, we added four recommendation letters that he obtained from other foremost experts in the field, asserting that our client’s findings not only advance the research of his peers in the pharmacology field, they also improve public health and pharmaceutical treatments around the world. Therefore, one of his recommenders stated:
Finally, our client splendidly achieved his EB-2 NIW approval without any hurdles. Thanks to our team’s efforts and constant follow-ups to support him. We are pleased to congratulate him on surpassing this challenge and moving one major step closer to obtain his green card.